Sign in

CIK 0001070081

  • Large accelerated filer

PTC THERAPEUTICS, INC.

Sign in to watch
Ticker
PTCT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
043416587
Phone
+1 908-222-7000
Business address
500 WARREN CORPORATE CENTER DRIVE, WARREN, NJ, 07059
Former names
PTC THERAPEUTICS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$5,916,619
in 9 filings, $5.9M under 10b5-1 plans

Net −$5,916,619. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2022-01-07 Reeve Emma Director Grant or award · Stock Option (Right To Buy) +12,000 12,000
2022-01-07 Okey Stephanie Director Grant or award +3,200 4,163
2022-01-07 Okey Stephanie Director Grant or award · Stock Option (Right To Buy) +12,000 12,000
2022-01-07 ZELDIS JEROME B Director Grant or award +3,200 6,500
2022-01-07 ZELDIS JEROME B Director Grant or award · Stock Option (Right To Buy) +12,000 12,000
2022-01-07 SOUTHWELL DAVID P Director Grant or award +3,200 6,500
2022-01-07 SOUTHWELL DAVID P Director Grant or award · Stock Option (Right To Buy) +12,000 12,000
2022-01-07 STEELE GLENN JR MD PHD Director Grant or award +3,200 6,500
2022-01-07 STEELE GLENN JR MD PHD Director Grant or award · Stock Option (Right To Buy) +12,000 12,000
2022-01-04 Almstead Neil Gregory Chief Technical Ops Officer Sale −64 $41.16 $3K 1,755
2022-01-04 Hill Emily Luisa Chief Financial Officer Sale −173 $41.16 $7K 23,133
2022-01-04 Pauwels Eric Chief Business Officer Sale −806 $41.16 $33K 35,386
2022-01-04 Peltz Stuart Walter Chief Executive Officer Sale −378 $41.16 $16K 22,834
2021-09-02 Boulding Mark Elliott Exec. VP and CLO Exercise or conversion +3,363 $18.01 $61K 51,737
2021-09-02 Boulding Mark Elliott Exec. VP and CLO Sale −3,363 $45.01 $151K 48,374
2021-09-02 Boulding Mark Elliott Exec. VP and CLO Exercise or conversion · Stock Option (Right to Buy) −3,363 $18.01 $61K 15,653
2021-08-13 Okey Stephanie Director Sale −1,650 $40.06 $66K 963
2021-07-09 Boulding Mark Elliott Exec. VP and CLO Exercise or conversion +548 $18.01 $10K 48,922
2021-07-09 Boulding Mark Elliott Exec. VP and CLO Sale −548 $45.00 $25K 48,374
2021-07-09 Boulding Mark Elliott Exec. VP and CLO Exercise or conversion +410 $18.01 $7K 48,784

Page 50 of 53 · 1,049 trades